Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis

AimsInternational criteria for the diagnosis of ocular sarcoidosis (OS) was established by the first International Workshop on Ocular Sarcoidosis (IWOS) and validations studies revealed certain limitations of the criteria. To overcome the limitations, revised IWOS criteria was established in an inte...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	British journal of ophthalmology Ročník 103; číslo 10; s. 1418 - 1422
Hlavní autoři:	Mochizuki, Manabu, Smith, Justine R, Takase, Hiroshi, Kaburaki, Toshikatsu, Acharya, Nisha R, Rao, Narsing A
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England BMJ Publishing Group LTD 01.10.2019
Témata:	Cytokines Diagnosis, Differential Diagnostic Techniques, Ophthalmological - standards Enzymes Eye Diseases - diagnosis Female Global Health Humans Internationality Male Medical diagnosis Patients Reference Standards Retrospective Studies Sarcoidosis Sarcoidosis - diagnosis Surveys and Questionnaires Terminology as Topic Tuberculosis Workshops Japan inflammation
ISSN:	0007-1161, 1468-2079, 1468-2079
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	AimsInternational criteria for the diagnosis of ocular sarcoidosis (OS) was established by the first International Workshop on Ocular Sarcoidosis (IWOS) and validations studies revealed certain limitations of the criteria. To overcome the limitations, revised IWOS criteria was established in an international meeting. This manuscript was aimed at reporting the revised IWOS criteria.MethodsA consensus workshop was carried out to discuss and revise the IWOS criteria. The workshop was held on 27 April 2017, in Nusa Dua, Bali, Indonesia. Prior to the workshop, a questionnaire proposing revised criteria and consisting of one item for differential diagnosis, seven items for ocular clinical signs, 10 items for systemic investigations and three categories of diagnostic criteria was circulated to 30 uveitis specialists. Questionnaire items with over 75% support were taken as consensus agreement; items with below 50% support were taken as consensus disagreement and items with 50%–75% support were discussed at the workshop. Of the latter items, those supported by two-thirds majority in the workshop were taken as consensus agreement.ResultsThe survey and subsequent workshop reached consensus agreements of the revised criteria for the diagnosis of OS as follows: (1) other causes of granulomatous uveitis must be ruled out; (2) seven intraocular clinical signs suggestive of OS; (3) eight results of systemic investigations in suspected OS and (4) three categories of diagnostic criteria depending on biopsy results and combination of intraocular signs and results of systemic investigations.ConclusionsRevised IWOS criteria were proposed by a consensus workshop.
AbstractList	AimsInternational criteria for the diagnosis of ocular sarcoidosis (OS) was established by the first International Workshop on Ocular Sarcoidosis (IWOS) and validations studies revealed certain limitations of the criteria. To overcome the limitations, revised IWOS criteria was established in an international meeting. This manuscript was aimed at reporting the revised IWOS criteria.MethodsA consensus workshop was carried out to discuss and revise the IWOS criteria. The workshop was held on 27 April 2017, in Nusa Dua, Bali, Indonesia. Prior to the workshop, a questionnaire proposing revised criteria and consisting of one item for differential diagnosis, seven items for ocular clinical signs, 10 items for systemic investigations and three categories of diagnostic criteria was circulated to 30 uveitis specialists. Questionnaire items with over 75% support were taken as consensus agreement; items with below 50% support were taken as consensus disagreement and items with 50%–75% support were discussed at the workshop. Of the latter items, those supported by two-thirds majority in the workshop were taken as consensus agreement.ResultsThe survey and subsequent workshop reached consensus agreements of the revised criteria for the diagnosis of OS as follows: (1) other causes of granulomatous uveitis must be ruled out; (2) seven intraocular clinical signs suggestive of OS; (3) eight results of systemic investigations in suspected OS and (4) three categories of diagnostic criteria depending on biopsy results and combination of intraocular signs and results of systemic investigations.ConclusionsRevised IWOS criteria were proposed by a consensus workshop. International criteria for the diagnosis of ocular sarcoidosis (OS) was established by the first International Workshop on Ocular Sarcoidosis (IWOS) and validations studies revealed certain limitations of the criteria. To overcome the limitations, revised IWOS criteria was established in an international meeting. This manuscript was aimed at reporting the revised IWOS criteria.AIMSInternational criteria for the diagnosis of ocular sarcoidosis (OS) was established by the first International Workshop on Ocular Sarcoidosis (IWOS) and validations studies revealed certain limitations of the criteria. To overcome the limitations, revised IWOS criteria was established in an international meeting. This manuscript was aimed at reporting the revised IWOS criteria.A consensus workshop was carried out to discuss and revise the IWOS criteria. The workshop was held on 27 April 2017, in Nusa Dua, Bali, Indonesia. Prior to the workshop, a questionnaire proposing revised criteria and consisting of one item for differential diagnosis, seven items for ocular clinical signs, 10 items for systemic investigations and three categories of diagnostic criteria was circulated to 30 uveitis specialists. Questionnaire items with over 75% support were taken as consensus agreement; items with below 50% support were taken as consensus disagreement and items with 50%-75% support were discussed at the workshop. Of the latter items, those supported by two-thirds majority in the workshop were taken as consensus agreement.METHODSA consensus workshop was carried out to discuss and revise the IWOS criteria. The workshop was held on 27 April 2017, in Nusa Dua, Bali, Indonesia. Prior to the workshop, a questionnaire proposing revised criteria and consisting of one item for differential diagnosis, seven items for ocular clinical signs, 10 items for systemic investigations and three categories of diagnostic criteria was circulated to 30 uveitis specialists. Questionnaire items with over 75% support were taken as consensus agreement; items with below 50% support were taken as consensus disagreement and items with 50%-75% support were discussed at the workshop. Of the latter items, those supported by two-thirds majority in the workshop were taken as consensus agreement.The survey and subsequent workshop reached consensus agreements of the revised criteria for the diagnosis of OS as follows: (1) other causes of granulomatous uveitis must be ruled out; (2) seven intraocular clinical signs suggestive of OS; (3) eight results of systemic investigations in suspected OS and (4) three categories of diagnostic criteria depending on biopsy results and combination of intraocular signs and results of systemic investigations.RESULTSThe survey and subsequent workshop reached consensus agreements of the revised criteria for the diagnosis of OS as follows: (1) other causes of granulomatous uveitis must be ruled out; (2) seven intraocular clinical signs suggestive of OS; (3) eight results of systemic investigations in suspected OS and (4) three categories of diagnostic criteria depending on biopsy results and combination of intraocular signs and results of systemic investigations.Revised IWOS criteria were proposed by a consensus workshop.CONCLUSIONSRevised IWOS criteria were proposed by a consensus workshop. International criteria for the diagnosis of ocular sarcoidosis (OS) was established by the first International Workshop on Ocular Sarcoidosis (IWOS) and validations studies revealed certain limitations of the criteria. To overcome the limitations, revised IWOS criteria was established in an international meeting. This manuscript was aimed at reporting the revised IWOS criteria. A consensus workshop was carried out to discuss and revise the IWOS criteria. The workshop was held on 27 April 2017, in Nusa Dua, Bali, Indonesia. Prior to the workshop, a questionnaire proposing revised criteria and consisting of one item for differential diagnosis, seven items for ocular clinical signs, 10 items for systemic investigations and three categories of diagnostic criteria was circulated to 30 uveitis specialists. Questionnaire items with over 75% support were taken as consensus agreement; items with below 50% support were taken as consensus disagreement and items with 50%-75% support were discussed at the workshop. Of the latter items, those supported by two-thirds majority in the workshop were taken as consensus agreement. The survey and subsequent workshop reached consensus agreements of the revised criteria for the diagnosis of OS as follows: (1) other causes of granulomatous uveitis must be ruled out; (2) seven intraocular clinical signs suggestive of OS; (3) eight results of systemic investigations in suspected OS and (4) three categories of diagnostic criteria depending on biopsy results and combination of intraocular signs and results of systemic investigations. Revised IWOS criteria were proposed by a consensus workshop.
Author	Acharya, Nisha R Mochizuki, Manabu Rao, Narsing A Smith, Justine R Takase, Hiroshi Kaburaki, Toshikatsu
Author_xml	– sequence: 1 givenname: Manabu surname: Mochizuki fullname: Mochizuki, Manabu email: m.manabu.oph@tmd.ac.jp organization: Miyata Eye Hospital, Miyakonojo, Japan – sequence: 2 givenname: Justine R surname: Smith fullname: Smith, Justine R email: m.manabu.oph@tmd.ac.jp organization: Flinders University School of Medicine and Public Health, Adelaide, South Australia, Australia – sequence: 3 givenname: Hiroshi surname: Takase fullname: Takase, Hiroshi email: m.manabu.oph@tmd.ac.jp organization: Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan – sequence: 4 givenname: Toshikatsu surname: Kaburaki fullname: Kaburaki, Toshikatsu email: m.manabu.oph@tmd.ac.jp organization: Department of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan – sequence: 5 givenname: Nisha R surname: Acharya fullname: Acharya, Nisha R email: m.manabu.oph@tmd.ac.jp organization: F. I. Proctor Foundation and Department of Ophthalmology, University of California San Francisco, San Francisco, California, USA – sequence: 6 givenname: Narsing A surname: Rao fullname: Rao, Narsing A email: m.manabu.oph@tmd.ac.jp organization: Department of Ophthalmology, USC Roski Eye Institute, Keck School of Medicine of University of Southern California, Los Angeles, California, USA
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/30798264$$D View this record in MEDLINE/PubMed
BookMark	eNqNkU1r3DAQhkVJaDZp_0IR9JIenOrb8qVQQj8WAgv5IEcjy6OutrK1lexA_32VOG1KTjlppHnmHc28x-hgjCMghCk5o5Srj90u7rfT1oQhhooRqitOOZfqFVpRoXR5qpsDtCKE1BWlih6h45x35coUrV-jI17ymimxQvES7nyGHtvkJ0je4OjweizhaCYfRxPwbUw_8zbucRzxxs7BJHxlko2-j9lnfLq-3Vx9wC4mPG0B9978GB8SRSgueH7C36BDZ0KGt4_nCbr5-uX6_Ht1sfm2Pv98UXVC8qnirmaSSgqdaqjquvJhUWsmei4cJSABBOONa4jVGnpDG91ZIcEKopnrneUn6HTR3af4a4Y8tYPPFkIwI8Q5t4xqqWsliSro-2foLs5l_FAo1nAluJayUO8eqbkboG_3yQ8m_W7_rrIAegFsijkncP8QStp719r_XWvvXWsX10rpp2el1k8P65-S8eElAnwR6Ibdy9v-AVu2tDI
CitedBy_id	crossref_primary_10_1007_s41030_021_00161_w crossref_primary_10_1080_09273948_2021_1884887 crossref_primary_10_1038_s41598_023_29159_x crossref_primary_10_1080_09273948_2024_2369931 crossref_primary_10_1080_09273948_2025_2532049 crossref_primary_10_1186_s12886_023_03081_2 crossref_primary_10_1016_j_survophthal_2021_06_003 crossref_primary_10_1007_s00417_024_06655_y crossref_primary_10_1136_bjo_2024_326240 crossref_primary_10_1097_ICB_0000000000001639 crossref_primary_10_1055_s_0040_1710536 crossref_primary_10_1080_09273948_2024_2302301 crossref_primary_10_1007_s00417_022_05701_x crossref_primary_10_3390_jpm12122075 crossref_primary_10_3390_diagnostics15070828 crossref_primary_10_1016_j_survophthal_2021_02_002 crossref_primary_10_1016_j_ajoc_2022_101525 crossref_primary_10_1080_09273948_2020_1850799 crossref_primary_10_1136_bjo_2024_325163 crossref_primary_10_4103_ijo_IJO_3150_21 crossref_primary_10_1080_09273948_2024_2439903 crossref_primary_10_1080_09273948_2024_2436633 crossref_primary_10_1016_j_ajo_2021_05_006 crossref_primary_10_1016_S0246_0343_25_47216_5 crossref_primary_10_1007_s00417_021_05527_z crossref_primary_10_1016_j_ophtha_2025_05_026 crossref_primary_10_1016_j_jaut_2024_103288 crossref_primary_10_1016_j_ajo_2021_01_025 crossref_primary_10_3389_fped_2022_881398 crossref_primary_10_7759_cureus_13076 crossref_primary_10_1080_09273948_2021_1970780 crossref_primary_10_1080_09273948_2024_2363481 crossref_primary_10_1080_09273948_2020_1857791 crossref_primary_10_1007_s10792_025_03629_9 crossref_primary_10_1016_j_resmer_2024_101127 crossref_primary_10_1016_j_ajo_2022_06_001 crossref_primary_10_1080_09273948_2023_2296617 crossref_primary_10_1007_s10384_021_00871_3 crossref_primary_10_1038_s41598_021_91340_x crossref_primary_10_3390_jcm11092525 crossref_primary_10_1080_09273948_2022_2150227 crossref_primary_10_1016_j_rmed_2021_106575 crossref_primary_10_1080_09273948_2020_1817503 crossref_primary_10_3390_cells10040766 crossref_primary_10_1080_09273948_2025_2544732 crossref_primary_10_1093_qjmed_hcaa171 crossref_primary_10_1097_ICU_0000000000000704 crossref_primary_10_1080_09273948_2025_2536049 crossref_primary_10_1080_09273948_2020_1861306 crossref_primary_10_3390_jcm11133606 crossref_primary_10_1016_j_jfop_2024_100120 crossref_primary_10_1080_17469899_2019_1613153 crossref_primary_10_1007_s00296_025_05818_2 crossref_primary_10_1055_a_2216_8879 crossref_primary_10_1016_j_ajo_2025_04_018 crossref_primary_10_3390_medicina58070898 crossref_primary_10_1186_s12886_025_04165_x crossref_primary_10_1186_s12348_020_0198_3 crossref_primary_10_1111_ceo_14366 crossref_primary_10_1016_j_jneuroim_2022_577851 crossref_primary_10_1016_j_ccm_2023_08_003 crossref_primary_10_1186_s42358_024_00381_z crossref_primary_10_1186_s40942_022_00412_1 crossref_primary_10_1080_09273948_2022_2089900 crossref_primary_10_1016_j_rcreue_2024_11_004 crossref_primary_10_1515_med_2025_1243 crossref_primary_10_2147_IMCRJ_S434632 crossref_primary_10_7861_clinmed_2022_0046 crossref_primary_10_1038_s41598_023_49894_5 crossref_primary_10_1007_s00417_022_05949_3 crossref_primary_10_1164_rccm_202002_0251ST crossref_primary_10_1038_s42003_024_06822_1 crossref_primary_10_1016_j_jfma_2021_12_032 crossref_primary_10_1016_j_revmed_2022_10_001 crossref_primary_10_1080_09273948_2025_2465773 crossref_primary_10_1016_j_aopr_2022_100047 crossref_primary_10_3389_fmed_2024_1348435 crossref_primary_10_1080_09273948_2019_1685109 crossref_primary_10_1080_09273948_2025_2553873 crossref_primary_10_1136_bcr_2024_261323 crossref_primary_10_1016_j_preteyeres_2023_101189 crossref_primary_10_3390_jcm12093194 crossref_primary_10_1093_ageing_afac203 crossref_primary_10_1007_s00347_023_01833_5 crossref_primary_10_1055_a_2132_6790 crossref_primary_10_1111_ceo_13856 crossref_primary_10_1136_bjophthalmol_2020_316563 crossref_primary_10_1016_j_heliyon_2022_e11218 crossref_primary_10_1097_OPX_0000000000001912 crossref_primary_10_1177_24741264251358628 crossref_primary_10_1016_j_jaut_2025_103375 crossref_primary_10_1080_08820538_2021_1900291 crossref_primary_10_1007_s00011_022_01601_2 crossref_primary_10_1007_s10384_020_00793_6 crossref_primary_10_3390_life15060882 crossref_primary_10_1007_s10792_021_01791_4 crossref_primary_10_1007_s10384_022_00927_y crossref_primary_10_1136_bjophthalmol_2020_317423 crossref_primary_10_1177_2515841420966451 crossref_primary_10_1007_s10792_025_03555_w crossref_primary_10_4103_sjopt_sjopt_221_24 crossref_primary_10_1177_2474126421996261 crossref_primary_10_1080_09273948_2023_2282609 crossref_primary_10_3390_ijms231810749 crossref_primary_10_1016_j_ajoc_2024_102220 crossref_primary_10_1016_j_monrhu_2021_03_007 crossref_primary_10_1007_s00417_020_05032_9 crossref_primary_10_1007_s12325_021_01832_5 crossref_primary_10_1080_1744666X_2023_2274363 crossref_primary_10_1016_j_ajo_2021_03_003 crossref_primary_10_1177_11206721231212776 crossref_primary_10_1080_09273948_2024_2334793 crossref_primary_10_1080_09273948_2022_2071744 crossref_primary_10_1186_s12969_021_00606_1 crossref_primary_10_1016_j_revmed_2025_03_048 crossref_primary_10_1080_09273948_2023_2258397 crossref_primary_10_1080_09273948_2022_2122513 crossref_primary_10_3390_jcm9123955 crossref_primary_10_1080_09273948_2021_1985522 crossref_primary_10_1111_ceo_14175 crossref_primary_10_1080_13816810_2021_1946701 crossref_primary_10_4103_IJO_IJO_3262_22 crossref_primary_10_3389_fmed_2021_732427 crossref_primary_10_1080_09273948_2025_2450484 crossref_primary_10_1016_j_revmed_2025_03_050 crossref_primary_10_1080_09273948_2023_2279683 crossref_primary_10_1136_bjophthalmol_2020_318657 crossref_primary_10_1186_s12886_024_03463_0 crossref_primary_10_1016_j_jaut_2024_103323 crossref_primary_10_1080_09273948_2020_1758159 crossref_primary_10_1007_s10792_021_01721_4 crossref_primary_10_1186_s12348_025_00504_7 crossref_primary_10_1080_09273948_2022_2073238 crossref_primary_10_1007_s00417_024_06422_z crossref_primary_10_1007_s11377_022_00642_7 crossref_primary_10_1080_09273948_2020_1791346 crossref_primary_10_1186_s12348_023_00364_z crossref_primary_10_1080_09273948_2023_2226203 crossref_primary_10_1186_s12886_025_04266_7 crossref_primary_10_1080_09273948_2021_1986726 crossref_primary_10_1080_09273948_2025_2450473 crossref_primary_10_1097_IAE_0000000000003405 crossref_primary_10_1038_s41433_025_03892_1 crossref_primary_10_1016_j_reumae_2021_11_001 crossref_primary_10_1001_jamaophthalmol_2021_3076 crossref_primary_10_1080_09273948_2022_2032189 crossref_primary_10_1080_09273948_2020_1830123 crossref_primary_10_1001_jamaophthalmol_2019_5704 crossref_primary_10_1080_09273948_2023_2271988 crossref_primary_10_3390_jcm10020281 crossref_primary_10_1080_09273948_2021_1980814 crossref_primary_10_1055_a_1148_2875 crossref_primary_10_1186_s12969_025_01078_3 crossref_primary_10_1136_bjophthalmol_2020_315960 crossref_primary_10_1016_j_resmer_2024_101142 crossref_primary_10_1167_iovs_61_11_4 crossref_primary_10_1007_s10792_020_01531_0 crossref_primary_10_1016_j_survophthal_2025_07_009 crossref_primary_10_1093_rheumatology_keae253 crossref_primary_10_4103_ijo_IJO_2830_21 crossref_primary_10_1038_s41433_024_03530_2 crossref_primary_10_1097_IAE_0000000000004482 crossref_primary_10_2147_OPTH_S376141 crossref_primary_10_4103_ijo_IJO_140_22 crossref_primary_10_1136_bjophthalmol_2020_317354 crossref_primary_10_1055_a_2009_0667 crossref_primary_10_1159_000503804 crossref_primary_10_1007_s10384_020_00809_1 crossref_primary_10_3390_diagnostics11040608 crossref_primary_10_1080_09273948_2024_2449179 crossref_primary_10_1097_IAE_0000000000003828 crossref_primary_10_1080_09273948_2020_1853782 crossref_primary_10_1097_MS9_0000000000000853 crossref_primary_10_3390_diagnostics13142451 crossref_primary_10_1080_09273948_2019_1678647 crossref_primary_10_3390_diagnostics12112703 crossref_primary_10_1016_j_jmii_2022_02_003 crossref_primary_10_4103_ijo_IJO_2159_21 crossref_primary_10_1016_j_revmed_2022_02_006 crossref_primary_10_1097_IAE_0000000000002864 crossref_primary_10_1007_s00417_024_06619_2 crossref_primary_10_1080_09273948_2024_2404077 crossref_primary_10_1186_s12348_023_00342_5 crossref_primary_10_1016_j_rmed_2024_107562 crossref_primary_10_1016_j_jcjo_2024_07_019 crossref_primary_10_1080_09273948_2022_2129693 crossref_primary_10_1080_09273948_2024_2435470 crossref_primary_10_1007_s00347_023_01814_8 crossref_primary_10_1007_s00393_022_01244_y crossref_primary_10_1007_s00508_024_02444_z crossref_primary_10_1007_s40123_020_00274_6 crossref_primary_10_3390_cells11010089 crossref_primary_10_1080_09273948_2021_1976216 crossref_primary_10_1038_s41598_022_07435_6 crossref_primary_10_1080_09273948_2020_1836565 crossref_primary_10_1080_09273948_2023_2276304 crossref_primary_10_1080_17476348_2023_2225772 crossref_primary_10_1038_s41433_021_01770_0 crossref_primary_10_4103_ijo_IJO_3099_21 crossref_primary_10_1093_rheumatology_keaa781
Cites_doi	10.1371/journal.pone.0154716 10.7878/jjsogd.35.3 10.1016/0002-9394(86)90001-2 10.1371/journal.pone.0147258 10.1016/j.resinv.2013.01.001 10.1056/NEJM199704243361706 10.3109/09273948.2015.1010094 10.1016/j.ophtha.2017.07.006 10.1016/j.ebiom.2016.04.024 10.1136/bjo.45.7.461 10.1097/00006982-200001000-00002 10.1016/j.rmed.2011.08.012 10.1007/s10384-006-0413-2 10.1016/S0896-1549(02)00021-4 10.1016/j.resinv.2013.12.003 10.1007/s10384-010-0873-2 10.1136/bjophthalmol-2015-307455 10.1111/j.1752-699X.2008.00126.x 10.1016/j.resinv.2012.02.001 10.1186/1479-5876-10-111 10.1136/bjo.65.5.348 10.1080/09273940902818861 10.3109/09273948.2015.1115082 10.1111/1346-8138.13792 10.1007/s10384-012-0158-z 10.1097/MD.0000000000005531
ContentType	Journal Article
Contributor	Cowan, Claude L LeHoang, Phuc Zierhut, Manfred Gon Yu, Hyeong Biswas, Jyotirmay Goldstein, Debra A Babu, Kalpana Hwang, Yih-Shiou McCluskey, Peter Mochizuki, Manabu Ohguro, Nobuyuki Sakai, Tsutomu Smith, Justine R Bodaghi, Bahram Jabs, Douglas A Ohno, Shigeaki P Jones, Nicholas Sukavatcharin, Somsiri Goto, Hiroshi Chhabra, Ramandeep Chee, Soon-Phaik Asyari, Fatma Ishihara, Mami Maruyama, Kazuichi Rao, Narsing A Kawashima, Hidetoshi Sonoda, Ko-Hei Khairallah, Moncef Tugal-Tutkun, Ilknur Takase, Hiroshi A Acharya, Nisha Murray, Philip I Okada, Annabelle A Accorinti, Massimo Namba, Kenichi Basu, Soumyava Sheu, Shwu-Jiuan Kaburaki, Toshikatsu
Contributor_xml	– sequence: 1 givenname: Massimo surname: Accorinti fullname: Accorinti, Massimo – sequence: 2 givenname: Nisha surname: A Acharya fullname: A Acharya, Nisha – sequence: 3 givenname: Fatma surname: Asyari fullname: Asyari, Fatma – sequence: 4 givenname: Kalpana surname: Babu fullname: Babu, Kalpana – sequence: 5 givenname: Soumyava surname: Basu fullname: Basu, Soumyava – sequence: 6 givenname: Jyotirmay surname: Biswas fullname: Biswas, Jyotirmay – sequence: 7 givenname: Bahram surname: Bodaghi fullname: Bodaghi, Bahram – sequence: 8 givenname: Soon-Phaik surname: Chee fullname: Chee, Soon-Phaik – sequence: 9 givenname: Ramandeep surname: Chhabra fullname: Chhabra, Ramandeep – sequence: 10 givenname: Claude L surname: Cowan fullname: Cowan, Claude L – sequence: 11 givenname: Debra A surname: Goldstein fullname: Goldstein, Debra A – sequence: 12 givenname: Hiroshi surname: Goto fullname: Goto, Hiroshi – sequence: 13 givenname: Yih-Shiou surname: Hwang fullname: Hwang, Yih-Shiou – sequence: 14 givenname: Mami surname: Ishihara fullname: Ishihara, Mami – sequence: 15 givenname: Douglas A surname: Jabs fullname: Jabs, Douglas A – sequence: 16 givenname: Nicholas surname: P Jones fullname: P Jones, Nicholas – sequence: 17 givenname: Toshikatsu surname: Kaburaki fullname: Kaburaki, Toshikatsu – sequence: 18 givenname: Hidetoshi surname: Kawashima fullname: Kawashima, Hidetoshi – sequence: 19 givenname: Moncef surname: Khairallah fullname: Khairallah, Moncef – sequence: 20 givenname: Phuc surname: LeHoang fullname: LeHoang, Phuc – sequence: 21 givenname: Kazuichi surname: Maruyama fullname: Maruyama, Kazuichi – sequence: 22 givenname: Peter surname: McCluskey fullname: McCluskey, Peter – sequence: 23 givenname: Manabu surname: Mochizuki fullname: Mochizuki, Manabu – sequence: 24 givenname: Philip I surname: Murray fullname: Murray, Philip I – sequence: 25 givenname: Kenichi surname: Namba fullname: Namba, Kenichi – sequence: 26 givenname: Nobuyuki surname: Ohguro fullname: Ohguro, Nobuyuki – sequence: 27 givenname: Shigeaki surname: Ohno fullname: Ohno, Shigeaki – sequence: 28 givenname: Annabelle A surname: Okada fullname: Okada, Annabelle A – sequence: 29 givenname: Narsing A surname: Rao fullname: Rao, Narsing A – sequence: 30 givenname: Tsutomu surname: Sakai fullname: Sakai, Tsutomu – sequence: 31 givenname: Shwu-Jiuan surname: Sheu fullname: Sheu, Shwu-Jiuan – sequence: 32 givenname: Justine R surname: Smith fullname: Smith, Justine R – sequence: 33 givenname: Ko-Hei surname: Sonoda fullname: Sonoda, Ko-Hei – sequence: 34 givenname: Somsiri surname: Sukavatcharin fullname: Sukavatcharin, Somsiri – sequence: 35 givenname: Hiroshi surname: Takase fullname: Takase, Hiroshi – sequence: 36 givenname: Ilknur surname: Tugal-Tutkun fullname: Tugal-Tutkun, Ilknur – sequence: 37 givenname: Hyeong surname: Gon Yu fullname: Gon Yu, Hyeong – sequence: 38 givenname: Manfred surname: Zierhut fullname: Zierhut, Manfred
Copyright	Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ. 2019 Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.
Copyright_xml	– notice: Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ. – notice: 2019 Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.
CorporateAuthor	International Workshop on Ocular Sarcoidosis Study Group
CorporateAuthor_xml	– name: International Workshop on Ocular Sarcoidosis Study Group
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR BTHHO CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8
DOI	10.1136/bjophthalmol-2018-313356
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland AUTh Library subscriptions: ProQuest Central BMJ Journals ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete ProQuest Health & Medical Research Collection Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) BMJ Journals Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	ProQuest One Academic Middle East (New) MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1468-2079
EndPage	1422
ExternalDocumentID	30798264 10_1136_bjophthalmol_2018_313356 bjophthalmol
Genre	Consensus Development Conference Journal Article
GeographicLocations	Japan
GeographicLocations_xml	– name: Japan
GroupedDBID	--- -~X .55 .GJ .VT 0R~ 18M 23N 2WC 354 39C 3O- 4.4 40O 53G 5GY 5RE 5VS 6J9 7X7 7~S 88E 8FI 8FJ 8R4 8R5 AAHLL AAKAS AAOJX AAWJN ABAAH ABJNI ABKDF ABMQD ABTFR ABUWG ABVAJ ACCCW ACGFO ACGFS ACGTL ACHTP ACMFJ ACNCT ACOAB ACOFX ACQSR ACTZY ADBBV ADCEG ADZCM AENEX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS ASPBG AVWKF AZFZN BAWUL BENPR BLJBA BOMFT BPHCQ BTFSW BTHHO BVXVI C1A C45 CAG CCPQU COF CS3 CXRWF DIK DU5 E3Z EBS EJD F5P FYUFA H13 HAJ HMCUK HYE HZ~ IAO IEA IHR IOF ITC J5H KQ8 L7B M1P N9A NTWIH NXWIF O9- OK1 OVD P2P PHGZT PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 TEORI TR2 UAW UKHRP UYXKK V24 VM9 W8F WH7 WOQ X7M XOL YFH YQY ZGI AAFWJ AAYXX ACQHZ AERUA AFFHD CITATION PHGZM PJZUB PPXIY 3V. CGR CUY CVF ECM EIF NPM RHF 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO
ID	FETCH-LOGICAL-b453t-3f725151eb6916bb30747824d34f10e5ee4239f90c88eda198bc45ec4082fdfc3
IEDL.DBID	BENPR
ISICitedReferencesCount	220
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000505163800012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0007-1161 1468-2079
IngestDate	Thu Oct 02 05:52:17 EDT 2025 Tue Oct 07 07:25:02 EDT 2025 Thu Jan 02 22:59:09 EST 2025 Sat Nov 29 03:06:03 EST 2025 Tue Nov 18 20:47:41 EST 2025 Fri Apr 25 03:29:13 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	10
Keywords	inflammation
Language	English
License	Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-b453t-3f725151eb6916bb30747824d34f10e5ee4239f90c88eda198bc45ec4082fdfc3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-News-1 ObjectType-Feature-4 ObjectType-Conference-2 content type line 23 ObjectType-Article-3
PMID	30798264
PQID	2293643855
PQPubID	2041039
PageCount	5
ParticipantIDs	proquest_miscellaneous_2185876506 proquest_journals_2293643855 pubmed_primary_30798264 crossref_primary_10_1136_bjophthalmol_2018_313356 crossref_citationtrail_10_1136_bjophthalmol_2018_313356 bmj_primary_10_1136_bjophthalmol_2018_313356
PublicationCentury	2000
PublicationDate	2019-10-01
PublicationDateYYYYMMDD	2019-10-01
PublicationDate_xml	– month: 10 year: 2019 text: 2019-10-01 day: 01
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England – name: London
PublicationTitle	British journal of ophthalmology
PublicationTitleAlternate	Br J Ophthalmol
PublicationYear	2019
Publisher	BMJ Publishing Group LTD
Publisher_xml	– name: BMJ Publishing Group LTD
References	Maruyama, Inaba, Tamada 2016; 95 Jabs, Johns 1986; 102 Fang, Huang, Xu 2016; 11 Takase, Shimizu, Yamada 2010; 54 Hunninghake, Costabel, Ando 1999; 16 Spalton, Sanders 1981; 65 Acharya, Browne, Rao 2018; 125 Shigemura, Nasuhara, Konno 2012; 10 Danila, Norkūniene, Jurgauskienė 2009; 3 Kawaguchi, Hanada, Horie 2007; 51 Gundlach, Hoffmann, Prasse 2016; 11 Oda, Ishimoto, Yatera 2014; 52 Jones, Tsierkezou, Patton 2016; 100 Shijubo, Yamaguchi 2015; 35 Gupta, Kumar, Aggarwal 2011; 28 Babu, Bhat, Philips 2016; 24 Thorne, Brucker 2000; 20 Babu, Shukla, Philips 2017; 25 Ohguro, Sonoda, Takeuchi 2012; 56 Ohara, Okubo, Sasaki 1992; 36 Ishikawa, Hattori, Yokoyama 2012; 50 Jones 2002; 15 Newman, Rose, Maier 1997; 336 Eishi 2013; 51 Crick, Hoyle, Smellie 1961; 45 Herbort, Rao, Mochizuki 2009; 17 Mostard, Voo, van Kroonenburgh 2011; 105 Thi Hong Nguyen, Kambe, Kishimoto 2017; 44 Vyas, Thangakunam, Gupta 2015; 31 Shen, Pang, Wu 2016; 8 Yamamoto, Sharma, Hosoda 1992; 9 2020050713022504000_103.10.1418.7 2020050713022504000_103.10.1418.6 Maruyama (2020050713022504000_103.10.1418.26) 2016; 95 2020050713022504000_103.10.1418.4 2020050713022504000_103.10.1418.18 Shen (2020050713022504000_103.10.1418.25) 2016; 8 Eishi (2020050713022504000_103.10.1418.29) 2013; 51 2020050713022504000_103.10.1418.2 2020050713022504000_103.10.1418.19 2020050713022504000_103.10.1418.17 2020050713022504000_103.10.1418.12 2020050713022504000_103.10.1418.9 2020050713022504000_103.10.1418.10 2020050713022504000_103.10.1418.11 Babu (2020050713022504000_103.10.1418.16) 2017; 25 Gupta (2020050713022504000_103.10.1418.30) 2011; 28 Babu (2020050713022504000_103.10.1418.27) 2016; 24 Hunninghake (2020050713022504000_103.10.1418.1) 1999; 16 Shigemura (2020050713022504000_103.10.1418.21) 2012; 10 Jabs (2020050713022504000_103.10.1418.5) 1986; 102 Oda (2020050713022504000_103.10.1418.24) 2014; 52 Acharya (2020050713022504000_103.10.1418.14) 2018; 125 Vyas (2020050713022504000_103.10.1418.31) 2015; 31 Ohara (2020050713022504000_103.10.1418.8) 1992; 36 2020050713022504000_103.10.1418.23 2020050713022504000_103.10.1418.22 2020050713022504000_103.10.1418.20 Fang (2020050713022504000_103.10.1418.28) 2016; 11 Yamamoto (2020050713022504000_103.10.1418.3) 1992; 9 Takase (2020050713022504000_103.10.1418.13) 2010; 54 Shijubo (2020050713022504000_103.10.1418.15) 2015; 35
References_xml	– volume: 9 start-page: 33 year: 1992 article-title: Special report: the 1991 descriptive definition of sarcoidosis publication-title: Sarcoidosis – volume: 11 start-page: e0154716 year: 2016 article-title: Immunological evidence for the role of mycobacteria in sarcoidosis: a meta-analysis publication-title: PLoS One doi: 10.1371/journal.pone.0154716 – volume: 35 start-page: 3 year: 2015 article-title: Diagnosis criteria and classification of disease severity for sarcoidosis in Japan publication-title: The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders doi: 10.7878/jjsogd.35.3 – volume: 31 start-page: 91 year: 2015 article-title: Interferon gamma release assay and tuberculin skin test positivity in sarcoidosis publication-title: Lung India – volume: 102 start-page: 297 year: 1986 article-title: Ocular involvement in chronic sarcoidosis publication-title: Am J Ophthalmol doi: 10.1016/0002-9394(86)90001-2 – volume: 11 start-page: e0147258 year: 2016 article-title: Interleukin-2 receptor and angiotensin-converting enzyme as markers for ocular sarcoidosis publication-title: PLoS One doi: 10.1371/journal.pone.0147258 – volume: 51 start-page: 56 year: 2013 article-title: Etiologic link between sarcoidosis and propionibacterium acnes publication-title: Respir Investig doi: 10.1016/j.resinv.2013.01.001 – volume: 336 start-page: 1224 year: 1997 article-title: Sarcoidosis publication-title: N Engl J Med doi: 10.1056/NEJM199704243361706 – volume: 24 start-page: 498 year: 2016 article-title: Review of results of quantiFERON TB gold test in presumed ocular tuberculosis in a south indian patient population publication-title: Ocul Immunol Inflamm doi: 10.3109/09273948.2015.1010094 – volume: 125 start-page: 119 year: 2018 article-title: Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients publication-title: Ophthalmology doi: 10.1016/j.ophtha.2017.07.006 – volume: 8 start-page: 302 year: 2016 article-title: Diagnostic performance of bronchoalveolar lavage fluid CD4/CD8 ratio for sarcoidosis: a meta-analysis publication-title: EBioMedicine doi: 10.1016/j.ebiom.2016.04.024 – volume: 45 start-page: 461 year: 1961 article-title: The eyes in sarcoidosis publication-title: Br J Ophthalmol doi: 10.1136/bjo.45.7.461 – volume: 20 start-page: 8 year: 2000 article-title: Choroidal white lesions as an early manifestation of sarcoidosis publication-title: Retina doi: 10.1097/00006982-200001000-00002 – volume: 105 start-page: 1917 year: 2011 article-title: Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis publication-title: Respir Med doi: 10.1016/j.rmed.2011.08.012 – volume: 51 start-page: 121 year: 2007 article-title: Evaluation of characteristic ocular signs and systemic investigations in ocular sarcoidosis patients publication-title: Jpn J Ophthalmol doi: 10.1007/s10384-006-0413-2 – volume: 16 start-page: 149 year: 1999 article-title: ATS/ERS/WASOG statement on sarcoidosis. American thoracic society/European respiratory society/world association of sarcoidosis and other granulomatous disorders publication-title: Sarcoidosis Vasc Diffuse Lung Dis – volume: 15 start-page: 319 year: 2002 article-title: Sarcoidosis and uveitis publication-title: Ophthalmol Clin North Am doi: 10.1016/S0896-1549(02)00021-4 – volume: 52 start-page: 179 year: 2014 article-title: Relationship between the ratios of CD4/CD8 T-lymphocytes in the bronchoalveolar lavage fluid and lymph nodes in patients with sarcoidosis publication-title: Respir Investig doi: 10.1016/j.resinv.2013.12.003 – volume: 54 start-page: 529 year: 2010 article-title: Validation of international criteria for the diagnosis of ocular sarcoidosis proposed by the first international workshop on ocular sarcoidosis publication-title: Jpn J Ophthalmol doi: 10.1007/s10384-010-0873-2 – volume: 100 start-page: 1393 year: 2016 article-title: Lymphopenia as a predictor of sarcoidosis in patients with uveitis publication-title: Br J Ophthalmol doi: 10.1136/bjophthalmol-2015-307455 – volume: 3 start-page: 214 year: 2009 article-title: Diagnostic role of BAL fluid CD4/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis publication-title: Clin Respir J doi: 10.1111/j.1752-699X.2008.00126.x – volume: 50 start-page: 3 year: 2012 article-title: Utility of KL-6/MUC1 in the clinical management of interstitial lung diseases publication-title: Respir Investig doi: 10.1016/j.resinv.2012.02.001 – volume: 10 start-page: 111 year: 2012 article-title: Effects of molecular structural variants on serum krebs von den lungen-6 levels in sarcoidosis publication-title: J Transl Med doi: 10.1186/1479-5876-10-111 – volume: 65 start-page: 348 year: 1981 article-title: Fundus changes in histologically confirmed sarcoidosis publication-title: Br J Ophthalmol doi: 10.1136/bjo.65.5.348 – volume: 28 start-page: 95 year: 2011 article-title: Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection publication-title: Sarcoidosis Vasc Diffuse Lung Dis – volume: 17 start-page: 160 year: 2009 article-title: International criteria for the diagnosis of ocular sarcoidosis: results of the first International Workshop On Ocular Sarcoidosis (IWOS) publication-title: Ocul Immunol Inflamm doi: 10.1080/09273940902818861 – volume: 25 start-page: 253 year: 2017 article-title: High resolution chest computerized tomography in the diagnosis of ocular sarcoidosis in a high TB endemic population publication-title: Ocul Immunol Inflamm doi: 10.3109/09273948.2015.1115082 – volume: 44 start-page: 789 year: 2017 article-title: Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement publication-title: J Dermatol doi: 10.1111/1346-8138.13792 – volume: 36 start-page: 452 year: 1992 article-title: Intraocular manifestations of systemic sarcoidosis publication-title: Jpn J Ophthalmol – volume: 56 start-page: 432 year: 2012 article-title: The 2009 prospective multi-center epidemiologic survey of uveitis in Japan publication-title: Jpn J Ophthalmol doi: 10.1007/s10384-012-0158-z – volume: 95 start-page: e5531 year: 2016 article-title: Vitreous lavage fluid and bronchoalveolar lavage fluid have equal diagnostic value in sarcoidosis publication-title: Medicine doi: 10.1097/MD.0000000000005531 – ident: 2020050713022504000_103.10.1418.18 doi: 10.1371/journal.pone.0147258 – ident: 2020050713022504000_103.10.1418.22 doi: 10.1136/bjophthalmol-2015-307455 – volume: 8 start-page: 302 year: 2016 ident: 2020050713022504000_103.10.1418.25 article-title: Diagnostic performance of bronchoalveolar lavage fluid CD4/CD8 ratio for sarcoidosis: a meta-analysis publication-title: EBioMedicine doi: 10.1016/j.ebiom.2016.04.024 – volume: 31 start-page: 91 year: 2015 ident: 2020050713022504000_103.10.1418.31 article-title: Interferon gamma release assay and tuberculin skin test positivity in sarcoidosis publication-title: Lung India – volume: 16 start-page: 149 year: 1999 ident: 2020050713022504000_103.10.1418.1 article-title: ATS/ERS/WASOG statement on sarcoidosis. American thoracic society/European respiratory society/world association of sarcoidosis and other granulomatous disorders publication-title: Sarcoidosis Vasc Diffuse Lung Dis – volume: 9 start-page: 33 year: 1992 ident: 2020050713022504000_103.10.1418.3 article-title: Special report: the 1991 descriptive definition of sarcoidosis publication-title: Sarcoidosis – ident: 2020050713022504000_103.10.1418.4 doi: 10.1136/bjo.45.7.461 – volume: 95 start-page: e5531 year: 2016 ident: 2020050713022504000_103.10.1418.26 article-title: Vitreous lavage fluid and bronchoalveolar lavage fluid have equal diagnostic value in sarcoidosis publication-title: Medicine doi: 10.1097/MD.0000000000005531 – volume: 51 start-page: 56 year: 2013 ident: 2020050713022504000_103.10.1418.29 article-title: Etiologic link between sarcoidosis and propionibacterium acnes publication-title: Respir Investig doi: 10.1016/j.resinv.2013.01.001 – volume: 54 start-page: 529 year: 2010 ident: 2020050713022504000_103.10.1418.13 article-title: Validation of international criteria for the diagnosis of ocular sarcoidosis proposed by the first international workshop on ocular sarcoidosis publication-title: Jpn J Ophthalmol doi: 10.1007/s10384-010-0873-2 – ident: 2020050713022504000_103.10.1418.9 doi: 10.1007/s10384-012-0158-z – ident: 2020050713022504000_103.10.1418.12 doi: 10.1080/09273940902818861 – ident: 2020050713022504000_103.10.1418.11 doi: 10.1097/00006982-200001000-00002 – ident: 2020050713022504000_103.10.1418.10 doi: 10.1136/bjo.65.5.348 – ident: 2020050713022504000_103.10.1418.19 doi: 10.1111/1346-8138.13792 – volume: 102 start-page: 297 year: 1986 ident: 2020050713022504000_103.10.1418.5 article-title: Ocular involvement in chronic sarcoidosis publication-title: Am J Ophthalmol doi: 10.1016/0002-9394(86)90001-2 – ident: 2020050713022504000_103.10.1418.20 doi: 10.1016/j.resinv.2012.02.001 – volume: 28 start-page: 95 year: 2011 ident: 2020050713022504000_103.10.1418.30 article-title: Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection publication-title: Sarcoidosis Vasc Diffuse Lung Dis – volume: 10 start-page: 111 year: 2012 ident: 2020050713022504000_103.10.1418.21 article-title: Effects of molecular structural variants on serum krebs von den lungen-6 levels in sarcoidosis publication-title: J Transl Med doi: 10.1186/1479-5876-10-111 – volume: 36 start-page: 452 year: 1992 ident: 2020050713022504000_103.10.1418.8 article-title: Intraocular manifestations of systemic sarcoidosis publication-title: Jpn J Ophthalmol – volume: 11 start-page: e0154716 year: 2016 ident: 2020050713022504000_103.10.1418.28 article-title: Immunological evidence for the role of mycobacteria in sarcoidosis: a meta-analysis publication-title: PLoS One doi: 10.1371/journal.pone.0154716 – ident: 2020050713022504000_103.10.1418.17 doi: 10.1016/j.rmed.2011.08.012 – volume: 25 start-page: 253 year: 2017 ident: 2020050713022504000_103.10.1418.16 article-title: High resolution chest computerized tomography in the diagnosis of ocular sarcoidosis in a high TB endemic population publication-title: Ocul Immunol Inflamm doi: 10.3109/09273948.2015.1115082 – volume: 52 start-page: 179 year: 2014 ident: 2020050713022504000_103.10.1418.24 article-title: Relationship between the ratios of CD4/CD8 T-lymphocytes in the bronchoalveolar lavage fluid and lymph nodes in patients with sarcoidosis publication-title: Respir Investig doi: 10.1016/j.resinv.2013.12.003 – volume: 24 start-page: 498 year: 2016 ident: 2020050713022504000_103.10.1418.27 article-title: Review of results of quantiFERON TB gold test in presumed ocular tuberculosis in a south indian patient population publication-title: Ocul Immunol Inflamm – ident: 2020050713022504000_103.10.1418.2 doi: 10.1056/NEJM199704243361706 – volume: 35 start-page: 3 year: 2015 ident: 2020050713022504000_103.10.1418.15 article-title: Diagnosis criteria and classification of disease severity for sarcoidosis in Japan publication-title: The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders doi: 10.7878/jjsogd.35.3 – ident: 2020050713022504000_103.10.1418.23 doi: 10.1111/j.1752-699X.2008.00126.x – ident: 2020050713022504000_103.10.1418.7 doi: 10.1007/s10384-006-0413-2 – volume: 125 start-page: 119 year: 2018 ident: 2020050713022504000_103.10.1418.14 article-title: Distinguishing features of ocular sarcoidosis in an international cohort of uveitis patients publication-title: Ophthalmology doi: 10.1016/j.ophtha.2017.07.006 – ident: 2020050713022504000_103.10.1418.6 doi: 10.1016/S0896-1549(02)00021-4
SSID	ssj0002617
Score	2.6543562
Snippet	AimsInternational criteria for the diagnosis of ocular sarcoidosis (OS) was established by the first International Workshop on Ocular Sarcoidosis (IWOS) and... International criteria for the diagnosis of ocular sarcoidosis (OS) was established by the first International Workshop on Ocular Sarcoidosis (IWOS) and...
SourceID	proquest pubmed crossref bmj
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	1418
SubjectTerms	Cytokines Diagnosis, Differential Diagnostic Techniques, Ophthalmological - standards Enzymes Eye Diseases - diagnosis Female Global Health Humans Internationality Male Medical diagnosis Patients Reference Standards Retrospective Studies Sarcoidosis Sarcoidosis - diagnosis Surveys and Questionnaires Terminology as Topic Tuberculosis Workshops
Title	Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis
URI	https://bjo.bmj.com/content/103/10/1418.full https://www.ncbi.nlm.nih.gov/pubmed/30798264 https://www.proquest.com/docview/2293643855 https://www.proquest.com/docview/2185876506
Volume	103
WOSCitedRecordID	wos000505163800012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1468-2079 dateEnd: 20250608 omitProxy: false ssIdentifier: ssj0002617 issn: 0007-1161 databaseCode: BENPR dateStart: 19220101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1468-2079 dateEnd: 20250608 omitProxy: false ssIdentifier: ssj0002617 issn: 0007-1161 databaseCode: 7X7 dateStart: 19220101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9NAEB6RFCEulFchtFSLxAEkrNjetdd7QrRq1UoQKl7Kzdqnkir1hjrl9zNrb1J6AFXi4su-LM_OzDcPzwC8LrgqjXImSSnNE6bQYFUoKRMnmVKVyDXv_pD78ZFPJtV0Ks6iw62NaZVrmdgJauN18JGPc9RLqD2roni__JmErlEhuhpbaAxgK1QqY0PYOjianH3ZyOJQb7wHwDzJENysc3loOVbnfjlbzeTiwi_wrmTBTUhpaGQ9UBfnN9XUX7Bnp4OOt__37R_Cg4g-yYf-ujyCO7Z5DPc-xfj6E_AhVNBaQ1CWhCLOknhHbjgNSfCutzO_JL4hn7skVvIVmcXPjW_nLXlzihbsW4JQmCC0JKbP5MMB3Mj309vr6U_h-_HRt8OTJLZkSBQr6CqhjiMgKjKrSsSVCska6u_nzFDmstQW1oaCgk6kuqqskZmolGaF1aGttTNO0x0YNr6xz4EoqtPSUon4izKTZ1JaLqo0N85JkUkxgndIh3rZF92oO2OFlvWfZKsD2eqebCPga4LVOpY3D102FrdYmW1W3v60vTWd68j0bX1N5BG82gwju4YYjGysv8I5iI9QARUpbvGsv0ubQ_FjCrT22It_b74L9_FNRJ9RuAfD1eWVfQl39a_VvL3chwGf8u5Z7Udu-A2tihD3
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61BQEX3o-FAkYCCSSiJnESJweEEFB11e2CREF7M35qt9rGS7MF8af4jYzjZEsPoF564BzHz88z39jjGYCnOZOFllZHMaVplEk0WCVKysiKTMqyShVrX8h9GbHxuJxMqo9r8Kt_C-PdKnuZ2Apq7ZQ_I99KUS-h9izz_PXiW-SzRvnb1T6FRoDFrvn5A0225tXwHa7vszTdfr__difqsgpEMsvpMqKWoU7PEyMLpEYSe-ZDyKeZpplNYpMb42Pi2SpWZWm0QKNcqiw3ymdmttoqivWuwwWU48y7kLHJysBro5sHus2iBKlU7zlEiy154BbT5VTMD90ckZn4Q0lKfdrsdXl4cFop_oXpthpv-9r_NlfX4WrHrcmbsBluwJqpb8Klvc574BY4fxHSGE1QUvoQ1YI4S04diRJ_d9BM3YK4mnxoXXTJJxyHm2nXzBryfIj2-QuCRJ8gcSY6-CniB6zIheLNSfHb8PlchnsHNmpXm3tAJFVxYahAdkkznSZCGFaVcaqtFVUiqgG8xHXnixBShLemGC34nzDhHiY8wGQArAcIV13wdp9DZH6GP5PVn2dvbbPHFe9EWsNPQDWAJ6vPKIz8DZOojTvGMsj-UL3mMVZxN2B31ShOZoW2bHb_35U_hss7-3sjPhqOdx_AFexVFXwnN2FjeXRsHsJF9X05a44etXuPwNfzBvBvUmlp8w
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB61W1Rx4f1YKGAkkEAi2iSO8zggBLQrVi3LCijqLfip3WobL80WxF_j1zGOky09gHrpgbMdv_J55ht7PAPwhGUiVcKoIKQ0DhKBBqtASRkYngiRF7HMmhdyX_ay8Tg_OCgma_Crewvj3Co7mdgIamWlOyMfxKiXUHvmjA1M6xYx2R6-WnwLXAYpd9PapdPwENnVP3-g-Va_HG3jv34ax8Odz2_fBW2GgUAkjC4DajLU7yzSIkWaJHCULpx8nCiamCjUTGsXH88UocxzrTga6EImTEuXpdkoIym2uw4bGZIM1oONNzvjyceVHnCxzj35zoIIiVXnR0TTgTi0i-lyyudHdo44jdwRJaUuifa6ODo8qyL_wnsb_Te8-j-v3DW40rJu8tpvk-uwpqsbsPm-9Su4CdZdkdRaEZShLng1J9aQM4elxN0q1FO7ILYiHxrnXfIJ52FnytazmjwboeX-nKAJQJBSE-U9GLEAG7K-en1a_RbsX8h0b0OvspW-C0RQGaaacuSdNFFxxLnOijyMlTG8iHjRhxeIgXLhg42UjZFG0_JPyJQOMqWHTB-yDiylbMO6u-wi83N8Ga2-PH9vWx3GylbY1eUpwPrweFWMYsrdPfFK2xOsg7wQFS8LsYk7HserTnExC7Ryk3v_bvwRbCJuy73RePc-XMZBFd6pcgt6y-MT_QAuye_LWX38sN2IBL5eNIJ_AwHhdBM
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Revised+criteria+of+International+Workshop+on+Ocular+Sarcoidosis+%28IWOS%29+for+the+diagnosis+of+ocular+sarcoidosis&rft.jtitle=British+journal+of+ophthalmology&rft.au=Mochizuki%2C+Manabu&rft.au=Smith%2C+Justine+R&rft.au=Takase%2C+Hiroshi&rft.au=Kaburaki%2C+Toshikatsu&rft.date=2019-10-01&rft.pub=BMJ+Publishing+Group+LTD&rft.issn=0007-1161&rft.eissn=1468-2079&rft.volume=103&rft.issue=10&rft.spage=1418&rft_id=info:doi/10.1136%2Fbjophthalmol-2018-313356&rft.externalDBID=HAS_PDF_LINK
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-1161&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-1161&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-1161&client=summon